An announcement from Elicio Therapeutics ( (ELTX) ) is now available.
Elicio Therapeutics has appointed Robert Connelly as its Principal Accounting and Financial Officer, bringing nearly four decades of leadership experience in the life sciences sector. His extensive background includes roles as CEO at multiple companies and board memberships with both public and private biotechnology firms, making his appointment a significant move for those watching Elicio’s strategic growth in the financial market.
See more data about ELTX stock on TipRanks’ Stock Analysis page.
